scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF00257121 |
P698 | PubMed publication ID | 6467500 |
P50 | author | Atholl Johnston | Q53067237 |
Vernon Harvey | Q126720724 | ||
P2093 | author name string | P Turner | |
P F Wrigley | |||
M L Slevin | |||
M J Barnett | |||
R C Woollard | |||
P2860 | cites work | High dose methotrexate with leucovorin rescue. Rationale and spectrum of antitumor activity | Q38579498 |
The clinical pharmacology of methotrexate.new applications of an old drug | Q39716312 | ||
Comparison of serum concentrations of methotrexate after various routes of administration | Q43982160 | ||
Enhancement of methotrexate absorption by subdivision of dose | Q44147246 | ||
Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia? | Q51657521 | ||
Effect of route of administration and effusions on methotrexate pharmacokinetics. | Q54451334 | ||
Outpatient chemotherapy for breast cancer | Q66876992 | ||
Comparison of intravenous and oral high-dose methotrexate in treatment of solid tumours | Q66904658 | ||
Assay of Therapeutic Doses of Methotrexate in Body Fluids of Patients with Psoriasis | Q66919758 | ||
Bioavailability of methotrexate: implications for clinical use | Q66992156 | ||
The metabolic fate of tritiated methotrexate. II. Absorption and excretion in man | Q68552830 | ||
Blood Levels of Methotrexate and the Treatment of Psoriasis | Q70569950 | ||
Clinical pharmacology of intermediate-dose oral methotrexate | Q71236275 | ||
STRIPE: an interactive computer program for the analysis of drug pharmacokinetics | Q71245588 | ||
Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia | Q72063971 | ||
Combination chemotherapy using high or low dose methotrexate for small cell carcinoma of the lung — A randomised trial | Q72415984 | ||
Improved prognosis of diffuse histiocytic and undifferentiated lymphoma by use of high dose methotrexate alternating with standard agents (M-BACOD) | Q72725584 | ||
The fluorometric measurement of the absorption, distribution and excretion of single doses of 4-amino-10-methyl pteroylglutamic acid (amethopterin) in man | Q74786929 | ||
P433 | issue | 2 | |
P921 | main subject | bioavailability | Q461809 |
chemotherapy | Q974135 | ||
P304 | page(s) | 91-94 | |
P577 | publication date | 1984-01-01 | |
P1433 | published in | Cancer Chemotherapy and Pharmacology | Q326137 |
P1476 | title | The bioavailability of oral intermediate-dose methotrexate. Effect of dose subdivision, formulation, and timing in the chemotherapy cycle | |
P478 | volume | 13 |
Q38396089 | Cancer chemotherapy in infants and children |
Q69912783 | Clinical pharmacology of oral intermediate-dose methotrexate with or without probenecid |
Q68758237 | Methotrexate bioavailability after oral and intramuscular administration in children |
Q39768346 | Pharmacokinetics of anticancer drugs in children |
Q67989804 | Relative bioavailability of oral low dose methotrexate. A comparison of 2 different formulations |
Search more.